[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343480-105":59,"doc-detail-343480-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","management-of-colorectal-neoplasia-in-ibd-patients-current-practice-and-future-perspectives","Management of Colorectal Neoplasia in IBD Patients - Current Practice and Future Perspectives","","Inflammatory bowel disease (IBD) patients have an elevated risk of colorectal neoplasia (CRN). This review provides an up-to-date overview and future perspectives on CRN management, emphasizing a shift from colectomy to endoscopic approaches as surveillance and resection techniques advance. Complete endoscopic resection is recommended when feasible, using cold snare polypectomy, endoscopic mucosal resection, or endoscopic submucosal dissection based on lesion complexity. When endoscopic resection is not feasible, multidisciplinary discussion guides surgery, while high synchronous and metachronous CRN rates require careful mucosal visualization and shortened surveillance intervals for at least five years.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/management-of-colorectal-neoplasia-in-ibd-patients-current-practice-and-future-perspectives/343480/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/management-of-colorectal-neoplasia-in-ibd-patients-current-practice-and-future-perspectives/343480.png","ImageObject",300,407,{"name":92,"@type":93},"River Wang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why are IBD patients at increased risk for colorectal cancer and CRN?","Question",{"text":113,"@type":114},"IBD patients have a 1.4–1.7 times increased risk of colorectal cancer compared with the general population, and chronic active inflammation is identified as the main driver of this increased risk.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What is the preferred management strategy for CRN in IBD when complete resection is feasible?",{"text":118,"@type":114},"Endoscopic treatment is recommended for all CRN if complete resection is feasible, using the appropriate technique—cold snare polypectomy, endoscopic mucosal resection, or endoscopic submucosal dissection—according to lesion complexity.",{"name":120,"@type":111,"acceptedAnswer":121},"How should surveillance be handled after CRN treatment in IBD?",{"text":122,"@type":114},"Because high synchronous and metachronous CRN rates are reported, careful mucosal visualization and shortened surveillance intervals are warranted for at least five years after CRN treatment.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},343480,1790145877,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","Management of Colorectal Neoplasia in IBD Patients: Current Practice and Future Perspectives  \nMonica E. W. Derks,a, Maarten te Groen,a, Lisa M. A. van Lierop,a,b Sanjay Murthy,c David T. Rubin,d,Talat Bessissow,e, Iris D. Nagtegaal,f Willem A. Bemelman,g  \nLauranne A. A. P. Derikx,h* Frank Hoentjena,b*  \na Inflammatory Bowel Disease Center, Department of Gastroenterology, Radboud University Medical Center, Nijmegen, The Netherlands  \nbDivision of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, AB, Canada c Ottawa Hospital IBD Center and Department of Medicine, University of Ottawa, Ottawa, ON, Canada dUniversity of Chicago Medicine Inflammatory Bowel Disease Center, University of Chicago, Chicago, IL, USA e Division of Gastroenterology, Department of Medicine, McGill University Health Center, Montreal, QC, Canada fDepartment of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands  \ngDepartment of Surgery, Amsterdam University Medical Center, AMC, Amsterdam, The Netherlands hDepartment of Gastroenterology, Erasmus Medical Center, Rotterdam, The Netherlands  \nCorresponding author: Monica Derks, MD, Radboud University Medical Center, Department of Gastroenterology, Geert Grooteplein-Zuid 8, 6525GA, Nijmegen, The Netherlands. Tel.: +31 [0]24 361 1111; [E-mail:](E-mail: monica.derks@radboudumc.nl)[ monica.derks@radboudumc.nl](E-mail: monica.derks@radboudumc.nl)  \n*Shared senior authorship.  \nAbstract  \nInflammatory bowel disease [IBD] patients are at increased risk of developing colorectal neoplasia [CRN] . In this review, we aim to provide an up-to-date overview and future perspectives on CRN management in IBD. Advances in endoscopic surveillance and resection techniques have resulted in a shift towards endoscopic management of neoplastic lesions in place of surgery. Endoscopic treatment is recommended for all CRN if complete resection is feasible. Standard [cold snare] polypectomy, endoscopic mucosal resection and endoscopic submucosal dissection should be performed depending on lesion complexity [size, delineation, morphology, surface architecture, submucosal fibrosis/invasion] to maximise the likelihood of complete resection. If complete resection is not feasible, surgical treatment options should be discussed by a multidisciplinary team. Whereas [sub]total and proctocolectomy play an important role in management of endoscopically unresectable CRN, partial colectomy may be considered in a subgroup of patients in endoscopic remission with limited disease extent without other CRN risk factors. High synchronous and metachronous CRN rates warrant careful mucosal visualisation with shortened intervals for at least 5 years after treatment of CRN.  \nKey Words: Inflammatory bowel disease; ulcerative colitis; Crohn’s disease; colorectal neoplasia; colorectal cancer; surveillance  \n1. Introduction  \nInflammatory bowel disease [IBD] patients are at a 1.4–1.7 times increased risk of developing colorectal cancer [CRC], compared with the general population.1–4 It is widely accepted that chronic active inflammation is the main driver underlying this increased risk.5–7 Improved disease control due to tight monitoring, stringent treatment, and the introduction of new biologic and small molecule therapies has resulted in a decreased CRC risk over time.2,3,8,9 However, colorectal neoplasia [CRN] risk is still increased, particularly in specific high-risk subgroups of IBD patients.  \nEndoscopic surveillance was put in place in order to detect and remove CRN at an early stage.10–12 Since the introduction of fibre-optic endoscopy in the 1960s, the diagnostic and therapeutic arsenal to manage CRN has significantly expanded. Previously invisible lesions are now detectable with high-definition white light endoscopy and dye-based [DCE] or virtual chromoendoscopy [VCE] . Moreover, improved endoscopic resection techniques enable radical resection,  \nreducing the need for colectomy. Nevertheless, surgery remai","cbCaijbxqXwCwWha","https://ap.wps.com/l/cbCaijbxqXwCwWha","pdf",789594,"English","# Abstract\n# Key points\n# 1. Introduction\n# 2. Diagnostic approach\n## 2.1. Endoscopic assessment","[{\"question\":\"Why are IBD patients at increased risk for colorectal cancer and CRN?\",\"answer\":\"IBD patients have a 1.4–1.7 times increased risk of colorectal cancer compared with the general population, and chronic active inflammation is identified as the main driver of this increased risk.\"},{\"question\":\"What is the preferred management strategy for CRN in IBD when complete resection is feasible?\",\"answer\":\"Endoscopic treatment is recommended for all CRN if complete resection is feasible, using the appropriate technique—cold snare polypectomy, endoscopic mucosal resection, or endoscopic submucosal dissection—according to lesion complexity.\"},{\"question\":\"How should surveillance be handled after CRN treatment in IBD?\",\"answer\":\"Because high synchronous and metachronous CRN rates are reported, careful mucosal visualization and shortened surveillance intervals are warranted for at least five years after CRN treatment.\"}]","Management of Colorectal Neoplasia in IBD Patients - Current Practice and Future Perspectives | PDF",1790051271,25,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0286d31dff6c1ff56532c1390f38743c.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f5fe44cc51a533f1abf6484a8ff44ba3.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/86fdcd12e0c221b2c3d47619606c5167.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c482831324e2f3da25e2a0bf58dee7e7.webp",980,1287]